143 related articles for article (PubMed ID: 3264367)
1. Heterogeneity of childhood acute lymphoblastic leukemia (ALL): monoclonal antibodies phenotyping and induction of differentiation in vitro.
Umiel T; Luria D; Stark B; Cohen IJ; Gozes Y; Kobiler D; Kodman Y; Grunspan A; Dvir A; Yaniv I
Leukemia; 1988 Dec; 2(12 Suppl):88S-96S. PubMed ID: 3264367
[TBL] [Abstract][Full Text] [Related]
2. Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-rosette co-expression.
Cantù-Rajnoldi A; Putti MC; Schirò R; Biondi A; Cattoretti G; Valeggio C; Castagni M; Basso G
Haematologica; 1992; 77(5):384-91. PubMed ID: 1362385
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
4. T cell receptor gene rearrangements in B-precursor acute lymphoblastic leukemia correlate with age and the stage of B cell differentiation.
Nuss R; Kitchingman G; Cross A; Zipf TF; Antoun GR; Bernstein I; Behm F; Pullen DJ; Crist W; Mirro J
Leukemia; 1988 Nov; 2(11):722-7. PubMed ID: 2972889
[TBL] [Abstract][Full Text] [Related]
5. [Stages of B-lymphocyte differentiation in acute lymphoblastic leukemia].
Koehler M; Bubała H; Sońta-Jakimczyk D; Guzikowska E; Janik-Moszant A; Wieczorek M; Hołowiecki J
Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):879-81, 884. PubMed ID: 2487942
[TBL] [Abstract][Full Text] [Related]
6. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
7. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
Wiersma SR; Ortega J; Sobel E; Weinberg KI
N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
[TBL] [Abstract][Full Text] [Related]
8. Genotypic characterization of common acute lymphoblastic leukemia may improve the phenotypic classification.
Foa R; Migone N; Fierro MT; Basso G; Lusso P; Putti MC; Giubellino MC; Saitta M; Miniero R; Casorati G
Exp Hematol; 1987 Oct; 15(9):942-5. PubMed ID: 3115807
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic heterogeneity and aberrant markers expression in T-cell leukemia.
Babusíková O; Glasová M; Koníková E; Kusenda J; Cáp J; Gyárfás J; Koubek K
Neoplasma; 1998; 45(3):128-34. PubMed ID: 9717523
[TBL] [Abstract][Full Text] [Related]
10. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
[TBL] [Abstract][Full Text] [Related]
11. [Cell origin of 18 patients with non-T, non-B acute lymphoblastic leukemia].
Tang MH
Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):345-7. PubMed ID: 2482806
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia.
Nakase K; Kita K; Miwa H; Nishii K; Shiku H; Nasu K; Dohy H; Kyo T; Kamada N; Tsutani H
Cancer Detect Prev; 2001; 25(4):394-405. PubMed ID: 11531016
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
14. HLA-A11 is associated with poor prognosis in childhood acute lymphoblastic leukemia (ALL).
Orgad S; Cohen IJ; Neumann Y; Vogel R; Kende G; Ramot B; Zaizov R; Gazit E
Leukemia; 1988 Dec; 2(12 Suppl):79S-87S. PubMed ID: 3199882
[TBL] [Abstract][Full Text] [Related]
15. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping.
Sidorenko SP; Vetrova EP; Yurchenko OV; Berdova AG; Shlapatskaya LN; Gluzman DF
Neoplasma; 1992; 39(1):3-9. PubMed ID: 1528302
[TBL] [Abstract][Full Text] [Related]
17. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
Greaves MF
Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
[TBL] [Abstract][Full Text] [Related]
19. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
[TBL] [Abstract][Full Text] [Related]
20. Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice.
Kamel-Reid S; Dick JE; Greaves A; Murdoch B; Doedens M; Grunberger T; Thorner P; Freedman MH; Phillips RA; Letarte M
Leukemia; 1992 Jan; 6(1):8-17. PubMed ID: 1531243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
